We are thrilled to congratulate the JARDIANCE US HCP Marketing Team from Boehringer Ingelheim and Eli Lilly and Company on being selected as an ELITE100 Marketing Team! Don’t miss a chance to meet them and all of our other incredible ELITE winners on June 18th at 230 FIFTH Rooftop in NYC for our celebration of the pharma industry’s best and brightest: https://lnkd.in/g4nE39eW
PM360 Magazine’s Post
More Relevant Posts
-
We had a great time presenting our Peer-to-Peer Power Breakfast with Jessica Greig (Sanofi) at Digital Pharma East 2024 last week. In case you missed it, check out our blog post recapping our 3 takeaways for pharma marketers. Read it here: https://lnkd.in/g6nF97ZZ #DigitalPharmaEast #DPE2024 #FiercePharma #PharmaMarketing
To view or add a comment, sign in
-
More and more pharma marketers understand that technological innovation drives success. Read on to hear more about how to navigate the challenges and opportunities new technology can offer.
We had a great time presenting our Peer-to-Peer Power Breakfast with Jessica Greig (Sanofi) at Digital Pharma East 2024 last week. In case you missed it, check out our blog post recapping our 3 takeaways for pharma marketers. Read it here: https://lnkd.in/g6nF97ZZ #DigitalPharmaEast #DPE2024 #FiercePharma #PharmaMarketing
3 Takeaways from Our Discussion with Jessica Greig at DPE2024
https://ixlayer.com
To view or add a comment, sign in
-
"Engagement" is a well-known term in marketing, and within the pharmaceutical industry, it assumes a particular form known as HCP (Healthcare Professional) engagement. While you may frequently encounter and use this term, it's crucial to recognize that traditional engagement strategies have become outdated. As the world evolves, so do the methods for capturing the attention of your target audience. Striking the perfect balance is a significant challenge. Many pharmaceutical companies and agencies face substantial obstacles that prevent them from reaching as many potential patients and healthcare professionals (HCPs) as possible. In this post, we will explore the concept of HCP engagement in depth ⬇️ For additional insights, be sure to check the comment section for bonus material created by Viseven CEO Nataliya Andreychuk, featured on pharmaphorum!
To view or add a comment, sign in
-
Chief Strategy Officer | B2B&DTC Marketing | Branding | Advertising | Social Media | Digital Marketing | SEO |
Join this webinar!
We are thrilled to announce that 3H Communications is proud to sponsor the upcoming National Pharmaceutical Congress End of Summer Webinar! With over 35 years of experience in the creative marketing industry, 3H Communications has been instrumental in delivering strategic communication and branding solutions that yield measurable results. Their expertise in crafting compelling narratives and innovative marketing strategies has consistently empowered clients to enhance their brand presence and engage effectively with their target audiences. Join us on September 11, 2024, from 11 a.m. to noon ET for this free webinar, where industry experts will share insights on career success in the evolving pharmaceutical landscape. Don’t miss this opportunity to connect with peers and leaders in the field! This is a fantastic opportunity to gain crucial skills from industry experts from leaders in the pharmaceutical field. We look forward to seeing you there! Register for free today: https://lnkd.in/gA2P3zuQ
To view or add a comment, sign in
-
Buckle up, pharma marketing innovators! The healthcare landscape is evolving at a breakneck speed, and one question echoes in every mind: What trends should pharma marketers be watching in 2024? We've tapped our most visionary leaders at OptimizeRx to share their predictions on the forces driving pharmaceutical marketing in the coming year, starting with our CEO, Will Febbo: "In 2024, I believe HCP marketing will truly become data-driven and clinical in orientation. HCPs have been vocal about their need for less 'spam' and more relevant, value-add brand information for decades. But today, the difference is that pharma can finally connect patient data to drive content relevancy, then deliver that content during specific care decision windows. As a result..." Read more: https://bit.ly/3tRRXgS
2024 Pharma Marketing Predictions: Better Execution Through Data and Technology
To view or add a comment, sign in
-
Pharma Marketers, are you ready for Digital Pharma East this September? This is your chance to immerse yourself in the premier event for pharmaceutical marketing professionals. Experience groundbreaking content and connect with industry leaders through unparalleled networking opportunities. Don’t miss out—register today! Stay updated on all Fierce events by following Fierce Life Sciences Events #DigitalPharmaEast #PharmaMarketing #Networking
Discover Breakthrough Pharma Marketing Strategies at Digital Pharma East 2024
fiercepharma.com
To view or add a comment, sign in
-
👩⚕️ Understanding US HCP Perceptions of Pharma Messaging: Explore the latest insights from CMI Media Group’s report on US HCP views of pharma manufacturers and their communication strategies. 🤔 Impact on Pharma Media: What quick pivots can brands action based on these insights on US HCPs? #solli #solliglobal #globalpharmamedia #cmimediagroup #HealthcareMarketing #PharmaInsights #HCP
CMI Media Group: Analyzes US HCP Perceptions of Pharma Messaging
https://solli.global
To view or add a comment, sign in
-
TA-Manager at Resonacle | Global Pharma Hiring Experts | Building High-Performing Workforces | Leadership Hiring |
🚀 Discover the Latest Trends in Pharma Marketing! 🌟 1. **Digital Revolution**: Embrace online platforms for targeted marketing and engagement. 2. **Personalized Medicine**: Tailor treatments for better patient outcomes. 3. **Patient Empowerment**: Shift towards patient-centric approaches. 4. **Value-Based Pricing**: Highlight product value for cost-conscious healthcare. 5. **Influencer Collaboration**: Partner with key opinion leaders (KOLs) for impactful messaging. Stay ahead of the curve in pharmaceutical marketing! 💡 #PharmaTrends #DigitalHealth #PatientCentric #InfluencerCollaboration
To view or add a comment, sign in
-
Behavioural Science & Pharmaceutical / Life Science Consultant; Keeping digital health human-centred / TV Guest Expert / Author
FirstWord Pharma spoke with Rashme Cardoza, Global Medical Affairs Consultant, formerly at GSK, about the future of pharma’s advisory boards and how their evolution is driving greater collaboration and innovation within the pharmaceutical industry. A few takeaways: 👩💻 Leveraging technology has revolutionized pharma's approach to seeking expertise and insights, allowing for greater accessibility, diversity, real-world evidence, and patient involvement, whilst being flexible and cost-effective. ⚕ This highlights the growing role of Medical Affairs, with a more strategic contribution to overall business decisions. 📏 Engagement metrics, reach, accessibility and decision impact are key to measuring effectiveness of virtual advisory boards. Read the full report here: https://lnkd.in/esktTKcE It was a pleasure interviewing you, Rashme Cardoza!
ViewPoints: Beyond the boardroom — the rise of virtual and patient-inclusive pharma advisory boards
ml.firstwordpharma.com
To view or add a comment, sign in
-
Independent Consultant | Formerly Director of Operations at Ghintell | Ex-WNS| Ex-SmartAnalyst | MBA | Life Sciences/ Pharma/ Biotech/ Consumer Healthcare | Research, Analytics & Consulting | Delivery Leader | Operations
Sanofi's Strategic Move: Spinning Off Consumer Healthcare to Unlock New Horizons In a strategic move mirroring industry trend, Sanofi recently has moved forward to spin off its consumer healthcare unit, following in the footsteps of pharmaceutical giants like GSK and Johnson & Johnson. This decision underscores the company's commitment to refocusing its efforts on its core biopharma business while creating a dedicated entity better equipped to navigate the dynamic consumer healthcare landscape. Tracing the precedents set by GSK's Haleon and Johnson & Johnson's Kenvue, Sanofi's spin-off highlights the growing recognition of the distinct demands and opportunities within the consumer healthcare sector. By separating these divisions, pharmaceutical companies can concentrate their resources on high-margin novel medicines, while the newly independent consumer healthcare companies can tailor their strategies to resonate with consumer preferences and drive growth in a highly competitive market. Key Impacts and Questions for Future Success: 1. Brand Revitalization: The spin-off presents an opportunity for Sanofi's consumer healthcare unit to revamp its marketing and branding efforts, aligning them more closely with consumer-focused markets. Investing in brand recognition and resonance will be crucial for establishing a strong presence. 2. Operational Agility: As an independent entity, the spun-off company will have greater flexibility to reshape its business model, streamline operations, and allocate resources more efficiently to meet changing market dynamics. 3. Innovation and Portfolio Expansion: With dedicated resources and a singular focus, the new company can accelerate innovation, explore strategic partnerships, and expand its product portfolio to capture emerging consumer trends and preferences. As the consumer healthcare industry continues to evolve, Sanofi's strategic spin-off presents both opportunities and challenges. By embracing agility, leveraging its inherited strengths, and fostering a consumer-centric mindset, the new entity can unlock its full potential and thrive in the dynamic consumer healthcare landscape.
To view or add a comment, sign in
4,288 followers